PAHC
Phibro Animal Health Corporation
NASDAQ: PAHC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$52.50
-3.30% today
Updated 2026-04-29
Market cap
$2.13B
P/E ratio
23.23
P/S ratio
1.45x
EPS (TTM)
$2.26
Dividend yield
0.88%
52W range
$18 – $60
Volume
0.3M
WallStSmart proprietary scores
67
out of 100
Grade: B
Buy
Investment rating
8.7
Growth
A6.5
Quality
B7.0
Profitability
B+6.7
Valuation
B3/9
Piotroski F-Score
Weak
2.1
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$51.20
-2.48%
12-Month target
$71.25
+35.71%
Intrinsic (DCF)
$128.61
Margin of safety
+59.94%
1 Strong Buy0 Buy2 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 31.80% — strong efficiency
+ Free cash flow $8.26M — positive
+ Revenue growth 20.90% QoQ
+ 59.94% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $942.26M | $977.89M | $1.02B | $1.30B | $1.46B |
| Net income | $49.17M | $32.61M | $2.42M | $48.26M | $27.46M |
| EPS | — | — | — | — | $2.26 |
| Free cash flow | $-5.39M | $-38.48M | $46.36M | $41.83M | $8.26M |
| Profit margin | 5.22% | 3.33% | 0.24% | 3.72% | 6.29% |
Peer comparison
Smart narrative
Phibro Animal Health Corporation trades at $52.50. representing a P/E of 23.23x trailing earnings. Our Smart Value Score of 67/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 2.09, it sits in the grey zone. TTM revenue stands at $1.46B. with profit margins at 6.29%. Our DCF model estimates intrinsic value at $128.61.
Frequently asked questions
What is Phibro Animal Health Corporation's stock price?
Phibro Animal Health Corporation (PAHC) trades at $52.50.
Is Phibro Animal Health Corporation overvalued?
Smart Value Score 67/100 (Grade B, Buy). DCF value $128.61.
What is the price target of Phibro Animal Health Corporation (PAHC)?
The analyst target price is $51.20, representing -2.5% downside from the current price of $52.50.
What is the intrinsic value of Phibro Animal Health Corporation (PAHC)?
Based on our DCF model, intrinsic value is $128.61, a +59.9% margin of safety versus $52.50.
What is Phibro Animal Health Corporation's revenue?
TTM revenue is $1.46B.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
2.09 — grey zone.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.45x
ROE31.80%
Beta0.69
50D MA$53.74
200D MA$42.34
Shares out0.02B
Float0.02B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—